The results demonstrated that maternal insulin resistance and hyperinsulinemia impair endocrine pancreas development and lead to metabolic disturbances in offspring, including higher postnatal glucose, insulin, leptin, glucagon, and GLP-1 levels, along with reduced β-cell area and proliferation [11,12]. The gene discussed is GCG; the disease is hyperinsulinism.